Here’s a roundup of just some of this past week’s pharmaceutical news items…
Everyone Wants A Piece Of Alnylam
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, has signed a deal to share rights and technology with Takeda Pharmaceuticals.
Express Scripts To Pay $9.5 Million In Settlement
Express Scripts, a pharmacy benefit manager, encouraged doctors to switch their patients’ cholesterol [...]
Out in internet land, some people are proposing to eliminate the FDA. Stella from ReasonPharm wrote about this issue on Monday and agreed, suggesting that other organizations, such as the media, independent licensing agencies, or clinical groups that develop practice guidelines might be able to step up and take over the FDA’s role. Eliminating the [...]
This week at the FDA — good news, bad news, and something about nipples:
The long-touted “Sentinel Initiative” program will finally get underway, using Medicare Part D claims data to search for adverse events or other drug-associated risks…
… Problems in China again, this time because the Chinese government may be delaying attempts by the FDA to [...]
Jennifer Buettner, a Maryland mother, claims that she was caring for her niece, who had a “nagging case of hypochondria”, when she came up with the idea to create a new drug for children. Actually, it’s not a drug and needs no approval from the FDA. It is a placebo pill, cleverly named Obecalp (placebo [...]
Memorial Day doesn’t have to be just one day, and my previous post about veterans’ health got me wondering about the care that my grandpa received from Veterans’ Affairs (VA). My grandpa served in World War II on a minesweeper for the U.S. Navy. Take a look at him and a shipmate in the photo [...]
The Dealbreaker blog is arguing here that universal health insurance coverage has nothing to do with shareholders. Do you agree? Shareholders care about profits and ROI… and a company with ballooning costs due to employee benefits and health care payments surely isn’t increasing its profits with all of that spending.
It may be true that the [...]
Jacob Goldstein at the WSJ health blog has picked up the story about shareholder voting on health care reform (click here to read his post). He also links to Xcel’s proxy (here). Their board is recommending a vote against the proposal. Interesting to note — Xcel’s Board of Directors includes Douglas Leatherdale, who also sits [...]
The New York Times reports today that the Securities and Exchange Commission is compelling companies to allow shareholders to vote on a proposal for universal health insurance coverage. While some companies have supported the idea of corporate America and its shareholders getting more involved in the health care reform debate, others have fought to [...]
Earlier this month an e-mail was sent by psychologist Dr. Norma Perez at Olin E. Teague Veterans’ Center in Temple, Texas to staff suggesting that they “refrain from giving a diagnosis of [post traumatic stress disorder] PTSD straight out.” Dr. Perez suggested that a diagnosis of “adjustment disorder” be given instead. This didn’t upset me [...]
Last night, I used part of a video series about international health care systems to get my Health Economics class talking. We should all be puzzled about why the U.S. spends so much more than other countries on health care, yet our health system is ranked by the World Health Organization squarely in the middle [...]
The inside info on the health care industry
Written by Jennifer Hinkel[email], and Becky Ramsey[email] for b5media.
Accounting Solver
Behind The Buzz
Biz Chicks Rule
Biz Levity
Brandcurve
Business & Blogging
Buzz Networker
Common Sense PR
Contract Worker
Daily Blender
Doing Biz Abroad
E-shop Owner
Everyday Networker
Franchise Pick
Greener Assets
Health Care Insiders
Home Biz Notes
Interview Chatter
Leadership Turn
My Organized Biz
One Vote Matters
Pimp Your Work
Project Management 411
Property Crossroads
Slacker Manager
Small Business Boomers
Startup Spark
Talk Stock Trading
The 501(c) Files
The Golden Pencil
Yielding Wealth
Recent Comments